SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported): August 2, 2006
LEAP WIRELESS INTERNATIONAL, INC.
(Exact name of registrant as specified in its charter)
|
|
|
|
|
Delaware
|
|
000-29752
|
|
33-0811062 |
|
|
|
|
|
(State or other jurisdiction of
incorporation)
|
|
(Commission
File Number)
|
|
(I.R.S. Employer
Identification No.) |
10307 Pacific Center Court
San Diego, California 92121
(Address of Principal Executive Offices)
(858) 882-6000
(Registrants telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy
the filing obligation of the registrant under any of the following provisions (see General
Instruction A.2. below):
o |
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
o |
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
o |
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b)) |
|
o |
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c)) |
TABLE OF CONTENTS
Item 1.01 Entry into a Material Definitive Agreement.
Item 5.02 Departure of Directors or Principal Officers; Election of Directors; Appointment of
Principal Officers.
On August 2, 2006, Leap Wireless International, Inc. (Leap or the Company) announced that
on July 25, 2006, Leaps Board of Directors appointed Mr. Amin I. Khalifa as Executive Vice
President and Chief Financial Officer of the Company, effective as of the date he begins his
employment with the Company, currently scheduled for August 28, 2006.
Mr. Khalifa, 52, previously served as Executive Vice President and Chief Financial Officer of
Apria Healthcare Group, Inc., a provider of home healthcare services, from October 2003 to August
2006. From June 1999 to September 2003, he served as Vice President and Chief Financial Officer of
Beckman Coulter, Inc., a manufacturer of diagnostic laboratory equipment and instruments. From
October 1996 to June 1999, Mr. Khalifa served as Chief Financial Officer of the Agricultural Sector
of Monsanto Company, a life sciences company. From 1994 to October 1996, he served as Senior Vice
President, Chief Financial Officer for Aetna Health Plans and as Senior Vice President, Strategy
and Investor Relations for Aetna, Inc. Mr. Khalifa currently serves as a director for PetSmart,
Inc. Mr. Khalifa holds a B.S. in industrial engineering and an M.B.A. in finance from Lehigh
University.
Mr. Khalifa will receive an annual base salary of $375,000, sign-on bonuses of $50,000 within
30 days of and on each of the first and second anniversaries of Mr. Khalifas initial date of
employment, and an opportunity to earn annual performance bonuses. Mr. Khalifas target performance
bonus will be 80% of his annual base salary with bonus payouts based on Company and individual
performance. In connection with his commencement of employment, Mr. Khalifa will be granted 35,000
restricted shares of the Companys common stock at a purchase price of $0.0001 per share and stock
options to purchase 175,000 shares of the Companys common stock at an exercise price equal to the
fair market value per share of Leap common stock on the date of his commencement of employment,
pursuant to the Companys 2004 Stock Option, Restricted Stock and Deferred Stock Unit Plan. In
addition, Mr. Khalifa will receive reasonable and customary relocation benefits. In connection
with his commencement of employment, Mr. Khalifa and the Company also expect to enter into the
Companys standard form of severance benefits agreement for executive officers, the form of which
was previously filed by the Company as Exhibit 10.4 to the Companys Quarterly Report on Form 10-Q
for the quarter ended September 30, 2005, as filed with the SEC on November 14, 2005.
The Company has not entered into any transactions with Mr. Khalifa of the type described under
Item 404(a) of Regulation S-K.
Mr. Dean Luvisa, the Companys Acting Chief Financial Officer, will continue to serve in that
capacity through the date Mr. Khalifa commences employment with the Company, at which time Mr.
Luvisa will continue as the Companys Vice President of Finance, reporting to the Companys
President and Chief Executive Officer.
2